Cancers are composed of populations of cells with distinct molecular and phenotypic features,
a phenomenon termed intratumor heterogeneity (ITH). ITH in lung cancers has not been …

Abstract Treatment with combined immune checkpoint blockade (CICB) targeting CTLA-4 and
PD-1 is associated with clinical benefit across tumor types, but also a high rate of immune-…

Immune checkpoint blockade produces clinical benefit in many patients. However, better
biomarkers of response are still needed, and mechanisms of resistance remain incompletely …

Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and
is an important cause of liver-related morbidity and mortality 1 . The standard of care therapy …

Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental syndrome
characterized by recurrent hemiplegic episodes and distinct neurological manifestations. …

Angiosarcoma is an aggressive malignancy that arises spontaneously or secondarily to
ionizing radiation or chronic lymphoedema 1 . Previous work has identified aberrant …

Clonal diversity is a consequence of cancer cell evolution driven by Darwinian selection.
Precise characterization of clonal architecture is essential to understand the evolutionary …

There is a growing body of evidence that therapy-related myeloid neoplasms (t-MNs) with
driver gene mutations arise in the background of clonal hematopoiesis (CH) under the positive …

Genomic intratumor heterogeneity (ITH) may be associated with postsurgical relapse of
localized lung adenocarcinomas. Recently, mutations, through generation of neoantigens, were …

Immunotherapy targeting T cells is increasingly utilized to treat solid tumors including non-small
cell lung cancer (NSCLC). This requires a better understanding of the T cells in the …